Formulary Monographs [ALPROSTADIL, 241292]

ALPROSTADIL
VASODILATING AGENTS, MISCELLANEOUS
Congenital heart disease in neonates until surgery is possible.
Infants: apnoea, fever, flushing, hypotension, bradycardia, tachycardia, diarrhoea, and convulsions.
Pediatric: Continuous intravenous infusion, initially 5 nanograms /kg/ minute, adjusted according to response, adjusted in steps of 5 nanograms/ kg / minute ( max . Per dose 100 nanograms /kg/minute),